Skip to content

Clinical trials

Skin Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Neoplasms Country / region: Netherlands Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20132
20141
20161
20172
20181
20201
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center6
Bristol-Myers Squibb2
Pfizer2
Idera Pharmaceuticals, Inc.1
Iovance Biotherapeutics, Inc.1
Nektar Therapeutics1
Netherlands Open University1
Novartis Pharmaceuticals1
The Netherlands Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Neoplasms16
Melanoma9
Neoplasm Metastasis5
Carcinoma, Squamous Cell3
Cutaneous Squamous Cell Carcinoma3
Squamous Cell Carcinoma of Head and Neck3
Basal Cell Carcinoma2
Carcinoma2
Neoplasms2
Recurrence2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.